156 related articles for article (PubMed ID: 8733757)
1. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats.
Hoffmann O; Wiesenfeld-Hallin Z
Neuroreport; 1996 Feb; 7(3):838-40. PubMed ID: 8733757
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats.
Plesan A; Hedman U; Xu XJ; Wiesenfeld-Hallin Z
Anesth Analg; 1998 Apr; 86(4):825-9. PubMed ID: 9539609
[TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
4. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
Bulka A; Wiesenfeld-Hallin Z; Xu XJ
Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
[TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys.
Allen RM; Granger AL; Dykstra LA
J Pharmacol Exp Ther; 2002 Feb; 300(2):435-41. PubMed ID: 11805202
[TBL] [Abstract][Full Text] [Related]
6. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
7. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
8. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
Popik P; Kozela E; Danysz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of dextromethorphan during pregnancy and throughout lactation significantly decreases the adverse effects associated with chronic morphine administration in rat offspring.
Tao PL; Yeh GC; Su CH; Wu YH
Life Sci; 2001 Oct; 69(20):2439-50. PubMed ID: 11681630
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
[TBL] [Abstract][Full Text] [Related]
11. The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats.
Hoffmann O; Wiesenfeld-Hallin Z
Neuroreport; 1994 Dec; 5(18):2565-8. PubMed ID: 7696605
[TBL] [Abstract][Full Text] [Related]
12. Genetic differences in the antinociceptive effect of morphine and its potentiation by dextromethorphan in rats.
Plesan A; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
Neurosci Lett; 1999 Mar; 263(1):53-6. PubMed ID: 10218909
[TBL] [Abstract][Full Text] [Related]
13. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
Baker AK; Hoffmann VL; Meert TF
Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
[TBL] [Abstract][Full Text] [Related]
14. Dextromethorphan potentiates morphine-induced antinociception at both spinal and supraspinal sites but is not related to the descending serotoninergic or adrenergic pathways.
Chow LH; Huang EY; Ho ST; Tsai SK; Tao PL
J Biomed Sci; 2004; 11(6):717-25. PubMed ID: 15591767
[TBL] [Abstract][Full Text] [Related]
15. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A
Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095
[TBL] [Abstract][Full Text] [Related]
16. Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.
Singh L; Oles RJ; Field MJ; Atwal P; Woodruff GN; Hunter JC
Br J Pharmacol; 1996 Jul; 118(5):1317-25. PubMed ID: 8818359
[TBL] [Abstract][Full Text] [Related]
17. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of dextromethorphan on the inhibitory effect of anti-NT4 on morphine tolerance.
Hatami H; Oryan S; Semnanian S; Kazemi B; Ahmadiani A
Pharmacology; 2006; 78(3):105-12. PubMed ID: 17003573
[TBL] [Abstract][Full Text] [Related]
19. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
20. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats.
Holtman JR; Jing X; Wala EP
Pharmacol Biochem Behav; 2003 Sep; 76(2):285-93. PubMed ID: 14592680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
